These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8197765)

  • 1. Adjuvant therapy of breast cancer.
    Davidson NE; Abeloff MD
    World J Surg; 1994; 18(1):112-6. PubMed ID: 8197765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pitfall in the survival benefit of adjuvant chemotherapy for node- and hormone receptor-positive patients with breast cancer: the paradoxical role of Bcl-2 oncoprotein (review).
    Kim R; Osaki A; Toge T
    Int J Oncol; 2001 Nov; 19(5):1075-80. PubMed ID: 11605012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant systemic therapy for lymph node-negative breast cancer less than or equal to 1 cm.
    Russell CA
    Curr Womens Health Rep; 2002 Apr; 2(2):134-9. PubMed ID: 12116603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes.
    Fisher B; Dignam J; Tan-Chiu E; Anderson S; Fisher ER; Wittliff JL; Wolmark N
    J Natl Cancer Inst; 2001 Jan; 93(2):112-20. PubMed ID: 11208880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
    CMAJ; 1998 Feb; 158 Suppl 3():S52-64. PubMed ID: 9484279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus conference. Adjuvant chemotherapy for breast cancer.
    JAMA; 1985 Dec; 254(24):3461-3. PubMed ID: 4068189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of chemotherapy and adjuvant therapy in the management of breast cancer in older women.
    Muss HB
    Cancer; 1994 Oct; 74(7 Suppl):2165-71. PubMed ID: 8087784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial data lacking for elderly patients with breast cancer.
    Nelson NJ
    J Natl Cancer Inst; 2000 Dec; 92(24):1968-9. PubMed ID: 11121451
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvant systemic therapy of stage I and II breast cancer.
    Goodman M
    Semin Oncol Nurs; 1991 Aug; 7(3):175-86. PubMed ID: 1833804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adjuvant chemotherapy of early stage breast cancer].
    Boér K
    Orv Hetil; 2010 Feb; 151(9):344-53. PubMed ID: 20159750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taxane evidence inconclusive in adjuvant setting.
    Randal J
    J Natl Cancer Inst; 2001 Feb; 93(3):168-9. PubMed ID: 11158179
    [No Abstract]   [Full Text] [Related]  

  • 13. Consensus panel endorses range of adjuvant therapies for breast cancer.
    McNeil C
    J Natl Cancer Inst; 2000 Dec; 92(23):1870. PubMed ID: 11106671
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant cytotoxic chemotherapy for early breast cancer: doubts and decisions.
    Dodwell DJ
    Lancet; 1998 May; 351(9114):1506-7. PubMed ID: 9605820
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant systemic therapy for women with node-negative breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
    CMAJ; 1998 Feb; 158 Suppl 3():S43-51. PubMed ID: 9484278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy.
    Gasparini G; Barbareschi M; Boracchi P; Verderio P; Caffo O; Meli S; Dalla Palma P; Marubini E; Bevilacqua P
    Cancer J Sci Am; 1995; 1(2):131-41. PubMed ID: 9166466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
    Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developments in breast cancer therapy.
    Lindley C
    J Am Pharm Assoc (Wash); 2002; 42(5 Suppl 1):S30-1. PubMed ID: 12296544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent advance in adjuvant therapy for breast cancer].
    Shimizu C; Watanabe T
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2458-69. PubMed ID: 12506467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic treatment for stage I and stage II breast cancer.
    Hudis CA; Borgen P
    Surg Oncol Clin N Am; 1997 Oct; 6(4):683-98. PubMed ID: 9309088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.